Shanghai - Delayed Quote CNY
Shanghai Model Organisms Center, Inc. (688265.SS)
28.59
+0.20
+(0.70%)
At close: June 13 at 3:00:03 PM GMT+8
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -0.38 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 688265.SS | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Related Tickers
33C.F InnoCare Pharma Ltd
1.5700
+7.53%
8EM.MU Editas Medicine Inc
1.8675
+3.49%
1VT.F Viking Therapeutics, Inc.
24.05
-3.41%
4RY.F Akeso, Inc.
10.40
-2.80%
1CG.SG CRISPR Therapeutics AG
35.60
+0.56%
6160.HK BeOne Medicines Ltd.
165.300
-1.90%
1801.HK INNOVENT BIO
80.700
-0.06%
2269.HK WuXi Biologics (Cayman) Inc.
28.000
+0.90%
NTLA Intellia Therapeutics, Inc.
8.31
-0.48%
CRSP CRISPR Therapeutics AG
41.36
+0.19%